Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Kosten TR, Wu G, Huang W, Harding MJ, Hamon SC, Lappalainen J, Nielsen DA.

Biol Psychiatry. 2013 Feb 1;73(3):219-24. doi: 10.1016/j.biopsych.2012.07.011. Epub 2012 Aug 18.

2.

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.

Shorter D, Nielsen DA, Huang W, Harding MJ, Hamon SC, Kosten TR.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1401-7. doi: 10.1016/j.euroneuro.2013.05.014. Epub 2013 Jul 10.

3.

Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.

Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR.

Drug Alcohol Depend. 2014 Mar 1;136:36-42. doi: 10.1016/j.drugalcdep.2013.12.007. Epub 2013 Dec 25.

PMID:
24462581
4.

DBH gene as predictor of response in a cocaine vaccine clinical trial.

Kosten TR, Domingo CB, Hamon SC, Nielsen DA.

Neurosci Lett. 2013 Apr 29;541:29-33. doi: 10.1016/j.neulet.2013.02.037. Epub 2013 Feb 28.

5.

ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.

Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA.

Pharmacogenet Genomics. 2013 Jul;23(7):333-40. doi: 10.1097/FPC.0b013e328361c39d.

6.

Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts.

Petrakis IL, Carroll KM, Nich C, Gordon LT, McCance-Katz EF, Frankforter T, Rounsaville BJ.

Addiction. 2000 Feb;95(2):219-28.

PMID:
10723850
7.

The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study.

Liu S, Green CE, Lane SD, Kosten TR, Moeller FG, Nielsen DA, Schmitz JM.

Pharmacogenet Genomics. 2014 Jul;24(7):370-3. doi: 10.1097/FPC.0000000000000055.

PMID:
24809448
8.

Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients.

Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR.

Drug Alcohol Depend. 2011 Jan 15;113(2-3):184-91. doi: 10.1016/j.drugalcdep.2010.07.022. Epub 2010 Sep 15.

9.

Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study.

Nielsen DA, Harding MJ, Hamon SC, Huang W, Kosten TR.

Genes Brain Behav. 2012 Nov;11(8):1001-8. doi: 10.1111/j.1601-183X.2012.00839.x. Epub 2012 Sep 27.

10.

A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia.

Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J.

Mol Psychiatry. 2000 Jan;5(1):56-63.

PMID:
10673769
11.

Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.

Arias AJ, Gelernter J, Gueorguieva R, Ralevski E, Petrakis IL.

Am J Addict. 2014 May-Jun;23(3):288-93. doi: 10.1111/j.1521-0391.2014.12102.x.

12.

Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients.

Jofre-Bonet M, Sindelar JL, Petrakis IL, Nich C, Frankforter T, Rounsaville BJ, Carroll KM.

J Subst Abuse Treat. 2004 Apr;26(3):225-32.

13.

The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency.

Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA.

Front Psychiatry. 2013 Jan 14;3:109. doi: 10.3389/fpsyt.2012.00109. eCollection 2012.

14.

A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function.

Köhnke MD, Zabetian CP, Anderson GM, Kolb W, Gaertner I, Buchkremer G, Vonthein R, Schick S, Lutz U, Köhnke AM, Cubells JF.

Biol Psychiatry. 2002 Dec 15;52(12):1151-8.

PMID:
12488060
15.

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Haile CN, Kosten TR, Kosten TA.

Am J Drug Alcohol Abuse. 2009;35(3):161-77. doi: 10.1080/00952990902825447. Review.

16.

Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration.

Kalayasiri R, Sughondhabirom A, Gueorguieva R, Coric V, Lynch WJ, Lappalainen J, Gelernter J, Cubells JF, Malison RT.

Biol Psychiatry. 2007 Jun 1;61(11):1310-3. Epub 2006 Dec 6.

PMID:
17157269
17.

mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse.

Gaval-Cruz M, Weinshenker D.

Mol Interv. 2009 Aug;9(4):175-87. doi: 10.1124/mi.9.4.6. Review.

18.

Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures.

Gaval-Cruz M, Schroeder JP, Liles LC, Javors MA, Weinshenker D.

Pharmacol Biochem Behav. 2008 Jun;89(4):556-62. doi: 10.1016/j.pbb.2008.02.009. Epub 2008 Feb 12.

19.

Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.

Bourdélat-Parks BN, Anderson GM, Donaldson ZR, Weiss JM, Bonsall RW, Emery MS, Liles LC, Weinshenker D.

Psychopharmacology (Berl). 2005 Nov;183(1):72-80. Epub 2005 Oct 22.

PMID:
16163519
20.

Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.

Ramaekers JG, van Wel JH, Spronk D, Franke B, Kenis G, Toennes SW, Kuypers KP, Theunissen EL, Stiers P, Verkes RJ.

Brain Imaging Behav. 2016 Dec;10(4):1254-1263.

Supplemental Content

Support Center